Bcs Wealth Management Pfizer Inc Transaction History

Bcs Wealth Management

$409 Million
Q3 2025

A detailed history of Bcs Wealth Management transactions in Pfizer Inc stock. As of the latest transaction made, Bcs Wealth Management holds 26,670 shares of PFE stock, worth $660,615. This represents 0.17% of its overall portfolio holdings.

Number of Shares

26,670

Previous 49,109 45.69%

Holding current value

$660,615

Previous $1.19 Million 42.94%

% of portfolio

0.17%

Previous 0.26%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 22, 2025	SELL	$23.29 - $25.88 $522,604 - $580,721	-22,439 Reduced 45.69%	26,670 $679,000
Q2 2025 Jul 15, 2025	BUY	$21.59 - $24.84 $93,463 - $107,532	4,329 Added 9.67%	49,109 $1.19 Million
Q1 2025 Apr 14, 2025	SELL	$25.01 - $27.13 $23,384 - $25,366	-935 Reduced 2.05%	44,780 $1.14 Million
Q4 2024 Jan 13, 2025	BUY	$24.8 - $30.19 $1.13 Million - $1.38 Million	45,715 New	45,715 $1.21 Million
Q1 2024 Apr 10, 2024	BUY	$25.89 - $29.73 $342,809 - $393,654	13,241 Added 50.44%	39,494 $1.1 Million
Q4 2023 Jan 11, 2024	SELL	$26.13 - $33.94 $4,050 - $5,260	-155 Reduced 0.59%	26,253 $756,000
Q3 2023 Oct 12, 2023	BUY	$32.09 - $37.51 $847,432 - $990,564	26,408 New	26,408 $876,000
Q1 2023 Apr 10, 2023	SELL	$39.39 - $51.28 $585,177 - $761,815	-14,856 Reduced 55.12%	12,095 $493,000
Q4 2022 Jan 10, 2023	BUY	$41.75 - $54.5 $334 - $436	8 Added 0.03%	26,951 $1.38 Million
Q3 2022 Oct 07, 2022	BUY	$43.76 - $53.42 $24,680 - $30,128	564 Added 2.14%	26,943 $1.18 Million
Q2 2022 Jul 29, 2022	BUY	$46.53 - $55.17 $21,031 - $24,936	452 Added 1.74%	26,379 $1.38 Million
Q1 2022 Apr 28, 2022	SELL	$45.75 - $56.69 $95,343 - $118,141	-2,084 Reduced 7.44%	25,927 $1.34 Million
Q4 2021 Jan 18, 2022	BUY	$41.32 - $61.25 $79,788 - $118,273	1,931 Added 7.4%	28,011 $1.65 Million
Q3 2021 Oct 25, 2021	BUY	$39.25 - $50.42 $41,094 - $52,789	1,047 Added 4.18%	26,080 $1.12 Million
Q2 2021 Jul 21, 2021	BUY	$35.91 - $40.68 $7,217 - $8,176	201 Added 0.81%	25,033 $980,000
Q1 2021 Apr 28, 2021	BUY	$33.49 - $37.77 $19,156 - $21,604	572 Added 2.36%	24,832 $900,000
Q4 2020 Jan 21, 2021	SELL	$33.47 - $42.56 $7,095 - $9,022	-212 Reduced 0.87%	24,260 $893,000
Q3 2020 Oct 23, 2020	SELL	$31.75 - $37.25 $249,999 - $293,306	-7,874 Reduced 24.34%	24,472 $898,000
Q2 2020 Jul 21, 2020	BUY	$30.12 - $36.54 $7,409 - $8,988	246 Added 0.77%	32,346 $1.06 Million
Q1 2020 Apr 10, 2020	BUY	$27.03 - $38.62 $867,663 - $1.24 Million	32,100 New	32,100 $1.05 Million

Others Institutions Holding PFE

# of Institutions

3,303

Shares Held

3.66B

Call Options Held

96M

Put Options Held

121M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $139B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bcs Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Bcs Wealth Management with notifications on news.

Account

Bcs Wealth Management Pfizer Inc Transaction History